Browsing Tag: Recombinant DNA Technology

Key Highlights:  Implications:  Obeda gives Dr. Reddy’s a second GLP‑1 foothold in India, but this time in the much bigger day‑to‑day diabetes market, not just injectable semaglutide. Because it ...